|Having trouble viewing this email? Click here|
Physicians: .25 AMA PRA Category I CreditsTM
To Receive Credit
In order to receive your certificate of participation, you should read the information about this activity, including the disclosure statements, review the entire activity, take the post-test, and complete the evaluation form. You may then follow the directions to print your certificate of participation. To begin, click the CME icon above.
Upon successful completion of this educational program, the reader should be able to:
Alan Ehrlich, MD
Dr. Ehrlich, Dr. Fleming, DynaMed Editorial Team members, and the staff of Antidote Education Company have disclosed that they have no relevant financial relationships or conflicts of interest with commercial interests related directly or indirectly to this educational activity.
ACCME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Antidote Education Company and EBSCO Publishing. Antidote is accredited by the ACCME to provide continuing medical education for physicians. Antidote Education Company designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Last week 553 journal articles were evaluated via DynaMed's Systematic Literature Surveillance and summaries of 197 articles were added to DynaMed content.
Percutaneous Closure of Left Atrial Appendage May Decrease the Risk of Death and Hemorrhagic Stroke Compared to Warfarin in Patients with Nonvalvular Atrial Fibrillation
Atrial fibrillation affects 1.5-2% of the general population and is associated with a five-fold increased risk of stroke (Eur Heart J 2012 Nov;33(21):2719). Antithrombotic therapy is consistently recommended for most patients with atrial fibrillation and until recently warfarin, a vitamin K antagonist, has been the antithrombotic of choice (J Am Coll Cardiol 2014 Mar 28 early online, Eur Heart J 2010 Oct;31(19):2369, Can J Cardiol 2012 Mar-Apr;28(2):125). Warfarin use requires monthly blood monitoring and is associated with an increased risk of bleeding. The left atrial appendage has been suggested as a major source of thromboembolism in patients with atrial fibrillation and left atrial appendage closure without long-term antithrombotic therapy may prevent stroke (Circulation 2002 Apr 23;105(16):1887). The PROTECT AF trial compared percutaneous device closure of left atrial appendage vs. warfarin in 707 patients with nonvalvular atrial fibrillation plus ≥ 1 risk factor for stroke including age ≥ 75 years, history of previous stroke or transient ischemic attack, hypertension, diabetes, heart failure, or left ventricular systolic dysfunction (Lancet 2009 Aug 15;374(9689):534). A four year follow-up of the PROTECT AF trial was recently published, providing long term efficacy and safety data.
The DynaMed editorial team is seeking specialist editors in the following fields: ENT, Gastroenterology, Hematology, Oncology (especially Breast cancer, Head and neck cancer, Pancreatic cancer), Ophthalmology, Orthopedics, Pediatric Endocrinology, Pediatric Neurology, and Vascular.
Free Trial of PEMSoft Mobile Available For iPhone, iPad, and Android Devices
The PEMSoft Mobile app, a pediatric evidence-based point-of-care medical reference tool for hospitals, emergency departments, clinics, pediatric group practices, transport services, and medical schools, is now available from EBSCO Health. Designed by pediatricians, emergency physicians and other medical specialists, the vast content in PEMSoft addresses the entire spectrum of neonatal, infant, child, adolescent and young adult health. PEMSoft authors adhere to a strict evidence-based editorial policy focused on systematic identification, evaluation and consolidation of practice-changing clinical literature.
DynaMed Contribution Opportunities
Call for Peer Reviews
We are currently seeking subspecialty reviewers for our Patient Education Resource Center (PERC). PERC provides fact sheets and discharge instructions for patients leaving the hospital or emergency room. These hand-outs fulfill the meaningful use requirements for the Medicare & Medicare Services Incentive Programs.